Increased risk of cardiovascular events with coxibs and NSAIDs

Lancet. 2005 Apr 30-May 6;365(9470):1537. doi: 10.1016/S0140-6736(05)66445-8.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Cardiovascular Diseases / chemically induced*
  • Cardiovascular Diseases / etiology
  • Cyclooxygenase Inhibitors / adverse effects*
  • Cyclooxygenase Inhibitors / therapeutic use
  • Humans
  • Lactones / adverse effects*
  • Lactones / therapeutic use
  • Osteoarthritis / complications
  • Osteoarthritis / drug therapy*
  • Risk Factors
  • Sulfones / adverse effects*
  • Sulfones / therapeutic use

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Cyclooxygenase Inhibitors
  • Lactones
  • Sulfones
  • rofecoxib